Recent Advances Using Phosphodiesterase 4 (PDE4) Inhibitors to Treat Inflammatory Disorders: Animal and Clinical Studies

Publisher： Bentham Science Publishers

E-ISSN： 2212-3903|11|1|21-40

ISSN： 1574-8855

Source： Current Drug Therapy, Vol.11, Iss.1, 2016-04, pp. : 21-40

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phosphodiesterase Type 4 Inhibitors: Potential in the Treatment of Multiple Sclerosis?

By Dinter H.  

BioDrugs, Vol. 13, Iss. 2, 2000-02 ,pp. : 87-94

Adis International

Access to resources Recommend Favorite

Clinical observations on the use of phosphodiesterase inhibitors as second-line inotropes in septic shock

By GRANT I S   MACKENZIE S J  

Clinical Intensive Care, Vol. 8, Iss. 1, 1997-02 ,pp. : 10-13

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Declawing of Neonatal Rabbits Destined for Use in Animal Biosafety Level 4 Containment Studies

By Perdue Kathy A.   Shaw Robyn E.   Mage Rose G.  

Journal of the American Association for Laboratory Animal Science, Vol. 39, Iss. 3, 2000-05 ,pp. : 13-18

American Association for Laboratory Animal Science

Access to resources Recommend Favorite

: Midwifery supervision 4. Clinical governance

By Jokhi Rachel  

The Practising Midwife, Vol. 17, Iss. 1, 2014-01 ,pp. : 30-33

Medical Education Solutions Limited

Access to resources Recommend Favorite

A Computerized Data-Capture System for Animal Biosafety Level 4 Laboratories

By Bente Dennis A   Friesen Jeremy   White Kyle   Koll Jordan   Kobinger Gary P  

Journal of the American Association for Laboratory Animal Science, Vol. 50, Iss. 5, 2011-09 ,pp. : 660-664

American Association for Laboratory Animal Science

Access to resources Recommend Favorite